Evidence map›Paper›PMID 26383770›Full record

ReviewBMC medical ethics2015

Ethical oversight in quality improvement and quality improvement research: new approaches to promote a learning health care system.

Kevin Fiscella, Jonathan N Tobin, Jennifer K Carroll, Hua He, Gbenga Ogedegbe

Abstract readReview
In one paragraph

Review in BMC medical ethics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Exploring the challenges of ethical conduct in quality improvement projects.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kevin FiscellaDepartment of Family Medicine, University of Rochester Medical Center, Rochester, USA. Kevin_fiscella@urmc.rochester.edu.
Jonathan N TobinClinical Directors Network (CDN), New York, NY, USA. jntobin@CDNetwork.org.
Jennifer K CarrollDepartment of Family Medicine, University of Colorado, Denver, USA. Jennifer.2.carroll@ucdenver.edu.
Hua HeDepartment of Biostatistics, University of Rochester Medical Center, Rochester, NY, USA. Hua_he@urmc.rochester.edu.
Gbenga OgedegbeDepartment of Population Health, Center for Healthful Behavior Change, New York University Langone Medical Center, New York, NY, USA. Olugbenga.Ogedegbe@nyumc.org.

Funding

Blood Pressure-Visit Intensification for Successful Improvement of TreatmentR18HL117801 · NHLBI · UNIVERSITY OF ROCHESTER · PI FISCELLA, KEVIN ANTHONY, TOBIN, JONATHAN N · 2013 to 2017
$3.3M
Implementation Research: Translating the ABC's into HIV CareU01HL142107 · NHLBI · UNIVERSITY OF ROCHESTER · PI FISCELLA, KEVIN ANTHONY · 2018 to 2021
$2.7M
Midcareer Investigator Award in Patient-Oriented Research for Dr. Gbenga OgedegbeK24HL111315 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI OGEDEGBE, OLUGBENGA G. · 2012 to 2016
$621k
NHLBI NIH HHS 1R18HL117801NHLBI NIH HHS K24 HL111315NHLBI NIH HHS R18 HL117801NHLBI NIH HHS U01 HL142107
6 · The paper itself

Abstract

backgroundInstitutional review boards (IRBs) distinguish health care quality improvement (QI) and health care quality improvement research (QIR) based primarily on the rigor of the methods used and the purported generalizability of the knowledge gained. Neither of these criteria holds up upon scrutiny. Rather, this apparently false dichotomy may foster under-protection of participants in QI projects and over-protection of participants within QIR. DISCUSSION: Minimal risk projects should entail minimal oversight including waivers for informed consent for both QI and QIR projects. Minimizing the burdens of conducting QIR, while ensuring minimal safeguards for QI projects, is needed to restore this imbalance in oversight. Potentially, such ethical oversight could be provided by the integration of Institutional Review Boards and Clinical Ethical Committees, using a more integrated and streamlined approach such as a two-step process involving a screening review, followed by a review by committee trained in QIR. Standards for such ethical review and training in these standards, coupled with rapid review cycles, could facilitate an appropriate level of oversight within the context of creating and sustaining learning health care systems. We argue that QI and QIR are not reliably distinguishable. We advocate for approaches that improve protections for QI participants while minimizing over-protection for participants in QIR through reasonable ethical oversight that aligns risk to participants in both QI and QIR with the needs of a learning health care system.

Indexed as

Biomedical ResearchDelivery of Health CareAttitude of Health PersonnelConfidentialityEthics Committees, ResearchHealth Services ResearchHumansInformed ConsentQuality Assurance, Health CareQuality Improvement

Identifiers

PMID26383770
PMCPMC4574354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.